The association of MMP-13 rs2252070 with non-small cell lung cancer in the Turkish population
DOI:
https://doi.org/10.30714/j-ebr.2023.190Keywords:
Non-small cell lung cancer, matrix metalloproteinase, variant, MMP-13, PCR-RFLPAbstract
Aim: To evaluate the role of MMP-13 rs2252070 in patients with non-small cell lung cancer (NSCLC) in the Turkish population.
Method: A total of 95 NSCLC patients and 94 healthy controls were included in this study. The MMP-13 rs2252070 variant was genotyped by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The results of the analyses were evaluated for statistical significance.
Results: There was no G/G homozygous genotype in the patient or control groups. The prevalence of genotypes of A/A and A/G profiles for the MMP-13 rs2252070 variant was 34.7% and 65.3%, respectively, in patients and 46.8% and 53.2%, respectively, in the control group. No significant difference was found between the patient and control groups in terms of MMP-13 rs2252070 genotype distribution and allele frequency (p= 0.091, OR: 0.605, CI 95%:0.337-1.086; p: 0.199, OR: 1.337, CI 95%: 0.858-2.083, respectively).
Conclusions: Our results in this study showed no association between MMP-13 rs2252070 and NSCLC. To fully comprehend the mechanisms underlying NSCLC development, more research is required.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Khumara Vagif Qizi, Fatih Karatas, Yasemin Oyaci, Murat Acat, Fatih Inci, Sacide Pehlivan

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright Holder-Author (s)